首頁 > 市場調查報告書 > 製藥

再生醫學

市場調查報告書

商品編碼

1490101

富血小板血漿市場：依類型、來源、應用、地區

Platelet Rich Plasma Market, By Type, By Origin, By Application, By Geography

出版日期: 2024年04月30日 | 出版商:

Coherent Market Insights | 英文 184 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球富血小板血漿市場規模為5.505億美元，預計2031年將達12.558億美元，2024年至2031年年複合成長率為12.5%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	5.505 億美元
實際資料	2019年至2023年	預測期	從2024年到2031年
預測 2024-2031 年年複合成長率：	12.50%	2031年價值預測	12.558 億美元

圖：2024 年按地區分類的富血小板血漿市場佔有率(%)

富血小板血漿（PRP）是從少量全血中提取的血小板濃縮物。 PRP 含有多種已知可促進組織再生的生長因子。 PRP 療法是一種即將推出的治療方法各種肌肉骨骼疾病（如肌腱炎、關節損傷和關節炎）的療法。血小板分泌的生長因子會透過吸引幹細胞並刺激細胞增生和分化來誘導組織癒合。隨著運動傷害和退化性疾病的日益流行，PRP 已成為外科手術和組織修復藥物的有前途的替代方案。

市場動態：

最近的趨勢表明，由於 PRP 的再生特性，PRP 在各個治療領域中得到了迅速採用。運動醫學的成長和肌肉骨骼疾病病例的增加是該市場的主要驅動力。然而，與 PRP 程序和設備相關的高成本可能會阻礙更廣泛的採用。廉價 PRP 製備套件的開發提供了重大機會。市場領導正在投資研發以擴大核准的臨床適應症。例如，監管機構核准PRP 在臉部回春中的使用開闢了新的途徑。

本研究的主要特點

本報告詳細分析了全球富血小板血漿市場，並提供了以 2023 年為基準年的預測期（2024-2031）的市場規模（百萬美元）和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球富血小板血漿市場的主要企業。
主要企業包括 Arthrex, Inc.、Ester Medical、Zimmer Biomet、Terumo Corporation、Glofinn Oy、Medira Ltd.、Regen Lab SA、CollPlant、Generex Biotechnology Corporation、Estar Technologies Ltd.、Cesca Therapeutics, Inc.、ArteriCell Medical Systems、Harvest Technologies Corp.、EmCyte Corporation、T-Biotechnology Ltd. 和Isto Biologics。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球富血小板血漿市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球富血小板血漿市場的各種策略矩陣來促進他們的決策。

公司簡介
- Arthrex, Inc.
- Ester Medical
- Zimmer Biomet
- Terumo Corporation
- Glofinn Oy
- Medira Ltd.
- Regen Lab SA
- CollPlant
- Generex Biotechnology Corporation
- Estar Technologies Ltd.
- Cesca Therapeutics, Inc.
- Arteriocyte Medical Systems
- Harvest Technologies Corp.
- EmCyte Corporation
- T-Biotechnology Ltd.
- Isto Biologics

第10章分析師建議

Wheel of Fortune
分析師觀點
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI936

The global platelet rich plasma market is estimated to be valued at USD 550.5 Mn in 2024 and is expected to reach USD 1,255.8 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 550.5 Mn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	12.50%	2031 Value Projection:	US$ 1,255.8 Mn

Figure. Platelet Rich Plasma Market Share (%), By Region, 2024

Platelet Rich Plasma (PRP) is an enriched concentration of platelets extracted from a small volume of whole blood. It contains several growth factors that are known to accelerate tissue regeneration. PRP therapy is an upcoming treatment for various musculoskeletal conditions such as tendonitis, joint injuries, and arthritis. The secretion of growth factors from platelets induces tissue healing by attracting stem cells and stimulating cell proliferation and differentiation. With the increasing prevalence of sports injuries and degenerative conditions, PRP is emerging as a promising alternative to surgical interventions and medications for tissue repair.

Market Dynamics:

Recent trends indicate the rapid adoption of PRP in various therapeutic areas due to its regenerative properties. Growth in sports medicine and rising cases of musculoskeletal disorders are major drivers for this market. However, high costs associated with PRP procedures and equipment may restrain wider adoption. The development of inexpensive PRP preparation kits presents significant opportunities. Market leaders are investing in R&D to expand approved clinical indications. For example, regulatory approvals for use of PRP in facial rejuvenation opens new avenues.

Key Features of the Study:

This report provides an in-depth analysis of the global platelet rich plasma market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global platelet rich plasma market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this Arthrex, Inc., Ester Medical, Zimmer Biomet, Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, Estar Technologies Ltd., Cesca Therapeutics, Inc., Arteriocyte Medical Systems, Harvest Technologies Corp., EmCyte Corporation, T-Biotechnology Ltd., and Isto Biologics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global platelet rich plasma market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global platelet rich plasma market.

Detailed Segmentation-

By Type:
- Pure PRP
- Leukocyte rich PRP
- Pure PRF
- Leukocyte rich PRF
By Origin:
- Autologous
- Allogenic
- Homologues
By Application:
- Neurosurgery
- Cosmetic Surgery
- Orthopedic Surgery
- General Surgery
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Arthrex, Inc.
- Ester Medical
- Zimmer Biomet
- Terumo Corporation
- Glofinn Oy
- Medira Ltd.
- Regen Lab S.A.
- CollPlant
- Generex Biotechnology Corporation
- Estar Technologies Ltd.
- Cesca Therapeutics, Inc.
- Arteriocyte Medical Systems
- Harvest Technologies Corp.
- EmCyte Corporation
- T-Biotechnology Ltd.
- Isto Biologics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Origin
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Platelet Rich Plasma Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Platelet Rich Plasma Market, By Type, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Pure PRP
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Leukocyte rich PRP
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Pure PRF
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Leukocyte rich PRF
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Platelet Rich Plasma Market, By Origin, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Autologous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Allogenic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Homologues
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Platelet Rich Plasma Market, By Application, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Neurosurgery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Cosmetic Surgery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Orthopedic Surgery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
General Surgery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Platelet Rich Plasma Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Arthrex, Inc.*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ester Medical
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Zimmer Biomet
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Terumo Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Glofinn Oy
- Medira Ltd.
- Regen Lab S.A.
- CollPlant
- Generex Biotechnology Corporation
- Estar Technologies Ltd.
- Cesca Therapeutics, Inc.
- Arteriocyte Medical Systems
- Harvest Technologies Corp.
- EmCyte Corporation
- T-Biotechnology Ltd.
- Isto Biologics